Bausch + Lomb Corporation Seeking to Enter Into New Credit Facilities to Facilitate Previously Announced Separation from Bausch Health Pharmaceutical Investing
Premier Health Completes the Previously Announced Acquisition of Canadian Health Care Agency Medical Device Investing
Bausch + Lomb Will Present New Scientific Data During the American Society of Cataract and Refractive Surgery Annual Meeting Pharmaceutical Investing
Danaher Announces Conversion Date For Series A Mandatory Convertible Preferred Stock Medical Device Investing
Applied UV Announces Global Technology Thought Leader John F. Andrews Joins As Chief Executive Officer and Director Medical Device Investing
